FNCHQ Finch Therapeutics Group, Inc.
Fundamentals / CIK 0001733257 / USDFinch Therapeutics Group, Inc. reported $0 in revenue and a net loss of $14.17M for the trailing twelve months ended June 30, 2024 (down 87.6% year over year).
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open FNCHQ in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue TTM$0 -87.6% YoY
-
Operating Income TTM-$19.50M Operating profit
-
Net Income TTM-$14.17M GAAP bottom line
-
Diluted EPS TTM-$8.82 Split-adjusted
-
Free Cash Flow TTM-$18.04M Operating CF less CapEx
-
Cash & ST Investments Jun 30, 2024$16.04M Total debt: $28.99M
Annual revenue and net income
4 fiscal years (2020 to 2023), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|
| Revenue | $107K | $861K | $18.53M | $7.72M |
| Research & Development | $7.20M | $52.86M | $57.28M | $33.14M |
| Total Operating Expenses | $83.97M | $116.5M | $78.52M | $47.16M |
| Operating Income | -$83.86M | -$115.6M | -$59.98M | -$39.44M |
| EBITDA | -$82.34M | -$110.1M | -$57.68M | -$38.65M |
| Income Before Tax | -$78.22M | -$114.6M | -$58.16M | -$39.34M |
| Income Tax Expense | -$3.46M | $0 | $0 | $0 |
| Net Income | -$74.75M | -$114.6M | -$58.16M | -$39.34M |
| Basic EPS | -$46.59 | -$72.12 | -$44.44 | -$145.04 |
| Diluted EPS | -$46.59 | -$72.12 | -$44.44 | -$145.04 |
| Basic Shares Outstanding | 1.6M | 1.6M | 1.3M | 271.2K |
| Diluted Shares Outstanding | 1.6M | 1.6M | 1.3M | 271.2K |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $107K | $8.0K | $138K |
| Research & Development | $0 | $0 | $0 | $0 | $203K | $7.00M | $11.55M | $11.86M |
| Total Operating Expenses | $6.11M | $5.20M | $4.42M | $3.78M | $9.88M | $65.89M | $27.76M | $40.77M |
| Operating Income | -$6.11M | -$5.20M | -$4.42M | -$3.78M | -$9.88M | -$65.78M | -$27.75M | -$40.63M |
| EBITDA | -$6.07M | -$5.16M | -$4.37M | -$3.73M | -$9.82M | -$64.42M | -$26.34M | -$39.23M |
| Income Before Tax | -$4.83M | -$3.88M | -$3.04M | -$2.42M | -$6.95M | -$65.81M | -$27.01M | -$40.37M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | -$3.46M | $0 | $0 |
| Net Income | -$4.83M | -$3.88M | -$3.04M | -$2.42M | -$6.95M | -$62.35M | -$27.01M | -$40.37M |
| Basic EPS | -$3.01 | -$2.41 | -- | -$1.51 | -$4.33 | -$39.19 | -- | -$25.38 |
| Diluted EPS | -$3.01 | -$2.41 | -- | -$1.51 | -$4.33 | -$39.19 | -- | -$25.38 |
| Basic Shares Outstanding | 1.6M | 1.6M | -- | 1.6M | 1.6M | 1.6M | -- | 1.6M |
| Diluted Shares Outstanding | 1.6M | 1.6M | -- | 1.6M | 1.6M | 1.6M | -- | 1.6M |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|
| Cash & Cash Equivalents | $25.12M | $71.04M | $133.5M | $99.71M |
| Cash & Short-Term Investments | $25.12M | $71.04M | $133.5M | $99.71M |
| Accounts Receivable, Net | $0 | $144K | $494K | $1.03M |
| Total Current Assets | $25.85M | $74.55M | $142.6M | $106.2M |
| Property, Plant & Equipment, Net | $594K | $15.94M | $19.64M | $7.00M |
| Goodwill | -- | $0 | $18.06M | $18.06M |
| Other Non-Current Assets | $0 | $4.03M | $4.91M | $200K |
| Total Non-Current Assets | $29.53M | $88.39M | $82.82M | $59.17M |
| Total Assets | $55.37M | $162.9M | $225.4M | $165.3M |
| Accounts Payable | $141K | $1.10M | $3.74M | $2.62M |
| Deferred Revenue (Current) | -- | -- | $0 | $3.37M |
| Total Current Liabilities | $4.08M | $14.69M | $14.79M | $11.49M |
| Long-Term Debt | $0 | $14.65M | $0 | $1.81M |
| Deferred Revenue (Non-Current) | -- | -- | $0 | $10.26M |
| Other Non-Current Liabilities | $0 | $170K | $7.0K | $221K |
| Total Non-Current Liabilities | $28.40M | $52.54M | $8.36M | $16.52M |
| Total Liabilities | $32.49M | $67.23M | $23.14M | $28.00M |
| Total Debt (incl. Leases) | $30.13M | $52.34M | $6.04M | $1.81M |
| Common Stock | $2.0K | $2.0K | $47K | $8.0K |
| Retained Earnings | -$350.4M | -$275.6M | -$161.0M | -$102.8M |
| Total Stockholders' Equity | $22.89M | $95.71M | $202.2M | -$95.72M |
| Total Equity | $22.89M | $95.71M | $202.2M | -$95.72M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $16.04M | $20.76M | $25.12M | $28.78M | $34.05M | $41.68M | $71.04M | $85.29M |
| Cash & Short-Term Investments | $16.04M | $20.76M | $25.12M | $28.78M | $34.05M | $41.68M | $71.04M | $85.29M |
| Accounts Receivable, Net | -- | -- | $0 | $0 | $0 | $107K | $144K | $0 |
| Total Current Assets | $17.28M | $21.18M | $25.85M | $29.92M | $36.50M | $43.40M | $74.55M | $90.62M |
| Property, Plant & Equipment, Net | $507K | $551K | $594K | $637K | $732K | $1.25M | $15.94M | $17.28M |
| Goodwill | -- | -- | -- | -- | -- | -- | $0 | $0 |
| Other Non-Current Assets | -- | -- | $0 | $0 | $0 | $200K | $4.03M | $4.25M |
| Total Non-Current Assets | $28.30M | $28.92M | $29.53M | $29.57M | $30.36M | $35.64M | $88.39M | $97.35M |
| Total Assets | $45.58M | $50.09M | $55.37M | $59.49M | $66.86M | $79.04M | $162.9M | $188.0M |
| Accounts Payable | $29K | $47K | $141K | $357K | $432K | $2.55M | $1.10M | $1.06M |
| Total Current Liabilities | $4.46M | $3.50M | $4.08M | $4.88M | $9.57M | $13.21M | $14.69M | $13.81M |
| Long-Term Debt | -- | -- | $0 | $0 | $0 | $0 | $14.65M | $14.64M |
| Other Non-Current Liabilities | -- | -- | $0 | $0 | $0 | $0 | $170K | $125K |
| Total Non-Current Liabilities | $26.89M | $27.55M | $28.40M | $28.80M | $29.39M | $32.88M | $52.54M | $53.29M |
| Total Liabilities | $31.36M | $31.05M | $32.49M | $33.68M | $38.96M | $46.09M | $67.23M | $67.10M |
| Total Debt (incl. Leases) | $28.99M | $29.56M | $30.13M | $30.77M | $31.04M | $36.13M | $52.34M | $52.36M |
| Common Stock | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $48K | $2.0K | $48K |
| Retained Earnings | -$359.1M | -$354.3M | -$350.4M | -$347.4M | -$344.9M | -$339.6M | -$275.6M | -$248.6M |
| Total Stockholders' Equity | $14.22M | $19.04M | $22.89M | $25.81M | $27.89M | $34.54M | $95.71M | $120.9M |
| Total Equity | $14.22M | $19.04M | $22.89M | $25.81M | $27.89M | $34.54M | $95.71M | $120.9M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|
| Net Income | -$74.75M | -$114.6M | -$58.16M | -$39.34M |
| Depreciation & Amortization | $1.52M | $5.51M | $2.30M | $790K |
| Stock-Based Compensation | $1.93M | $7.84M | $4.16M | $3.10M |
| Change in Receivables | $143K | $350K | $540K | $143K |
| Change in Payables | -$956K | -$2.26M | $2.26M | $440K |
| Operating Cash Flow | -$31.50M | -$74.85M | -$67.13M | -$31.33M |
| Capital Expenditure | $0 | -$2.18M | -$15.98M | -- |
| Free Cash Flow | -$31.50M | -$77.03M | -$83.12M | -- |
| Investing Cash Flow | $1.33M | -$2.18M | -$15.92M | -$2.63M |
| Financing Cash Flow | -$16.16M | $14.87M | $119.1M | $91.47M |
| Net Change in Cash | -$46.33M | -$62.16M | $36.06M | $57.51M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$4.83M | -$3.88M | -$3.04M | -$2.42M | -$6.95M | -$62.35M | -$27.01M | -$40.37M |
| Depreciation & Amortization | $44K | $43K | $44K | $52K | $57K | $1.37M | $1.41M | $1.41M |
| Stock-Based Compensation | $15K | $28K | $114K | $335K | $300K | $1.18M | $1.79M | $2.10M |
| Change in Receivables | $0 | $0 | -$1.0K | $0 | $107K | $37K | -$144K | $174K |
| Change in Payables | -$18K | -$94K | -$216K | -$76K | -$528K | -$136K | $37K | $135K |
| Operating Cash Flow | -$4.73M | -$4.36M | -$3.71M | -$5.26M | -$9.16M | -$13.38M | -$14.27M | -$19.09M |
| Capital Expenditure | $0 | $0 | $14K | $0 | $0 | -$14K | -$51K | -$328K |
| Free Cash Flow | -$4.73M | -$4.36M | -$3.69M | -$5.26M | -$9.16M | -$13.39M | -$14.32M | -$19.42M |
| Investing Cash Flow | $0 | $0 | $51K | $20K | $1.27M | -$14K | -$51K | -$328K |
| Financing Cash Flow | $0 | $0 | $0 | $0 | $4.0K | -$16.16M | $52K | $41K |
| Net Change in Cash | -$4.73M | -$4.36M | -$3.65M | -$5.24M | -$7.88M | -$29.55M | -$14.27M | -$19.38M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|
| Operating Margin | -78374.8% | -13425.4% | -323.7% | -510.9% |
| Net Profit Margin | -69863.6% | -13315.4% | -313.8% | -509.7% |
| Return on Equity (ROE) | -326.6% | -119.8% | -28.8% | -- |
| Return on Assets (ROA) | -135.0% | -70.4% | -25.8% | -23.8% |
| Current Ratio | 6.33x | 5.08x | 9.64x | 9.24x |
| Quick Ratio | 6.15x | 4.85x | 9.06x | 8.77x |
| Debt to Equity | 1.32x | 0.55x | 0.03x | -- |
| Revenue Growth (YoY) | -87.6% | -95.4% | +140.1% | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -- | -- | -78374.8% | -93214.8% | -56936.0% | -25536.8% | -13425.4% | -6443.8% |
| Net Profit Margin | -- | -- | -69863.6% | -85844.3% | -54022.1% | -24825.1% | -13315.4% | -6431.2% |
| Return on Equity (ROE) | -99.6% | -85.5% | -326.6% | -382.4% | -490.0% | -441.3% | -119.8% | -88.3% |
| Return on Assets (ROA) | -31.1% | -32.5% | -135.0% | -165.9% | -204.4% | -192.8% | -70.4% | -56.8% |
| Current Ratio | 3.87x | 6.05x | 6.33x | 6.13x | 3.81x | 3.29x | 5.08x | 6.56x |
| Quick Ratio | 3.59x | 5.93x | 6.15x | 5.90x | 3.56x | 3.16x | 4.85x | 6.18x |
| Debt to Equity | 2.04x | 1.55x | 1.32x | 1.19x | 1.11x | 1.05x | 0.55x | 0.43x |
| Revenue Growth (YoY) | -- | -100.0% | -100.0% | -100.0% | -100.0% | -69.8% | -99.0% | -98.8% |